Celsion changes name to Imunon (IMNN)

Sep. 19, 2022 4:36 PM ETImunon, Inc. (IMNN)By: Shweta Agarwal, SA News Editor2 Comments
  • Celsion (NASDAQ:CLSN) announced Monday its decision to change company's name to Imunon.
  • The new name of clinical-stage drug development company is claimed to outline the "evolution of its business and its commitment to developing cutting-edge immunotherapies and next-generation vaccines to treat cancer and infectious diseases."
  • Stock will begin trading under the new ticker symbol "IMNN", effective Sept 21, 2022.
  • "With a strong balance sheet supporting current operations into 2025, we are well positioned to build a differentiated company to deliver on the promise of our gene-based therapies," commented Dr. Corinne Le Goff, president and CEO of Imunon.
  • Earlier: Celsion says additional data shows placcine vaccine works against COVID-19 in animal model

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.